We’re helping position the nation as a global research and innovation nerve center with an ecosystem focused on developing ideas with impact.
Across the fields of IT, energy, environment, healthcare, and agribusiness, our Research, Development, and Innovation (RDI) division is leading the charge in bringing new technologies into the global marketplace.
By planning, coordinating, and overseeing RDI activity across our organization, the division is able to take a holistic view and identify new challenges and opportunities.
With every initiative, we remain focused on generating economic value, transferring knowledge, and establishing national and international RDI partnerships that align with Qatar’s needs and priorities.
Our ecosystem isn’t about infrastructure. It’s about ideas and enabling them to develop naturally to the point where they become commercialized products.
We don’t force innovation to happen. But we make sure it can.
Our research and innovation ecosystem is made up of RDI actors spanning the spectrum of academia, industry, technology entrepreneurship, healthcare, and public policy.
The division is responsible for translating national priorities into specific initiatives and actions for Qatar Foundation’s various RDI entities, ensuring alignment and synergy to deliver maximum national benefit and global impact.
Qatar Science & Technology Park (QSTP) is Qatar’s premier hub for applied research, technology innovation, incubation, and entrepreneurship. It is a ‘free zone’ that houses various international corporations (such as ExxonMobil, Shell, ConocoPhilips, Microsoft, Cisco), SMEs, research institutions, and local tech startups.
Qatar Biobank is a population-based research initiative that creates a repository of biological samples and information on health and lifestyle of Qatari citizens and long-term residents. This enables local scientists to conduct vital medical research on prevalent health issues in Qatar, thereby giving our people a better chance of avoiding serious illnesses in the future.
Qatar Genome Programme (QGP) is a population-based research project that aims to study the genetic makeup of the Qatari population with the aim of introducing precision medicine and personalized healthcare. Its large-scale genomic research, based on data collected by Qatar Biobank, has made Qatar one of the few countries in the world conducting research of this nature.
Story | Research
Noticing the many factors that cause delays in the delivery of parcels to people’s doorsteps, Ahmed Mohamedali and his co-founders created Airlift—currently incubated at Qatar Science & Technology Park—to develop autonomous vehicles that can efficiently deliver packages without any human assistance.
Our Research, Development, and Innovation division carries out its mission through three key functions.
We offer a number of initiatives at Qatar Science & Technology Park that help turn your ideas into impact. We’re always on the lookout for amazing initiatives and ambitious personalities to help take them to the next level.
The largest entrepreneurship boot-camp of its kind in the region, the Arab Innovation Academy is a collaboration between the European Innovation Academy and QSTP that helps participants establish a startup in just 10 days.
Our signature intensive two-month program is designed to provide aspiring entrepreneurs with training, and mentorship.
The QSTP Incubation Center is a 12-month technology-focused incubation program that aims to foster local tech entrepreneurship in Qatar.
We partnered with 500 Startups to bring their exclusive, coveted international Series A accelerator program here in Qatar.
It’s a three-month investment program that provides intensive one-on-one training and mentoring, and accepts a limited number of tech startups that have previously raised funding from other investors, but are now preparing to scale up.
Our research ecosystem has led to some significant progress in various industries.
Genomics may hold the key to understanding why a host of lifestyle factors and behaviors affect individuals differently, leading to earlier diagnoses and more effective treatments.
Personalized medicine and genomics medicine are the new era of medicine. There is a huge investment to work in preventive medicine, rather than just treating the patient after they become sick.
Story | Research
Many can relate to the experience of a relative or friend losing their life to an unforeseen cancerous disease or a heart attack at a young age, despite living a healthy lifestyle. Eighty percent of such rare diseases — which claim millions of lives worldwide every year — are known to be caused by genetic disorders. To prevent these diseases, many countries are now investing resources into genomics: the study of how genes function in a particular population.
There’s always something to do when you’re in Education City.
If you’ve got an idea for a project or would like to pursue a partnership with one of our institutes, please contact email@example.com